Navigation Links
Celator(R) Pharmaceuticals Announces Enrollment of First Patient in Phase 2 Study with CPX-351
Date:11/18/2008

Randomized study will enroll newly diagnosed, elderly AML patients

PRINCETON, N.J., Nov. 18 /PRNewswire/ -- Celator Pharmaceuticals today announced that the first patient has been treated in a randomized Phase 2 clinical study of CPX-351 (Cytarabine:Daunorubicin) Liposome Injection in patients with newly diagnosed acute myeloid leukemia (AML).

The first patient was enrolled by Eric Feldman, MD at the Weill Medical College of Cornell University and New York Presbyterian Hospital. Dr. Feldman was an investigator involved in the Phase 1 study with CPX-351 in patients with advanced leukemias. "We are pleased to be involved in this Phase 2 study based on the encouraging results seen in the Phase 1 study," said Dr. Feldman. "It's important to develop new treatment options for patients and CPX-351 incorporates two of the most active agents used in the treatment of AML."

CPX-351 is a liposomal formulation of cytarabine and daunorubicin delivered in a 5:1 molar ratio shown in preclinical studies to represent a synergistic ratio for use in combination chemotherapy. CPX-351 represents a new approach to developing drug combinations in which drug ratios are pre-selected based on synergistic anti-tumor activity observed preclinically and where the ratios are maintained in patients through Celator's proprietary CombiPlex(R) technology platform.

The Phase 2 study will be conducted in patients with newly diagnosed AML, greater than or equal to 60 but <76 years of age, who are able to tolerate intensive chemotherapy. This randomized (2:1) study is designed to compare CPX-351 to the conventional method of administering cytarabine and daunorubicin, commonly referred to as "7+3." The reference "7+3" refers to the administration days of the drugs (cytarabine is administered as a 7 day continuous infusion and daunorubicin is administered on days 1, 2 and 3). CPX-351 is administer
'/>"/>

SOURCE Celator Pharmaceuticals
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Celator(R) Pharmaceuticals Announces Positive Phase 2 Results for CPX-1 in Treatment of Colorectal Cancer
2. Celator(R) Pharmaceuticals Successfully Uses Nanoparticles to Administer Hydrophobic Drug Combinations
3. Celator(R) Pharmaceuticals Reports CPX-351 Shows Anti-Cancer Activity in Leukemia Patients
4. Raptor Pharmaceuticals Corp. Announces Positive Phase IIa Clinical Study Results for Convivia(TM) Program
5. Raptor Pharmaceuticals to Collaborate with Centre Hospitalier Universitaire dAngers for Phase II Clinical Trial in Huntingtons Disease
6. VIA Pharmaceuticals Announces Positive Results of Phase 2 Studies of VIA-2291 in Patients With Serious Cardiovascular Disease
7. Cadence Pharmaceuticals Reports Third Quarter 2008 Financial Results and Provides Clinical Development Programs Update
8. Poniard Pharmaceuticals Announces Final Top-Line Results from Phase 1 Trial Demonstrating Positive Bioavailability with Oral Picoplatin
9. VIA Pharmaceuticals Announces Conference Call and Webcast to Discuss VIA-2291 Phase 2 Data Presentations at AHA
10. Sunesis Pharmaceuticals Presents Clinical Trial Data of Voreloxin in Patients with Acute Myeloid Leukemia and Ovarian Cancer at the Chemotherapy Foundation Symposium
11. Raptor Pharmaceuticals Provides Update on Targeting Platforms
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)...   Life Line Screening  (LLS), a leading ... creation of a unique partnership with MCM Solutions ... is a population health management organization. LLS will provide ... These important expanded services will help MCM and its ... reduces cost of care when individuals are able to ...
(Date:5/22/2013)... 2013  Flagship Ventures, a leading venture capital ... sustainability, today announced the appointment of ... In this role, Mr. Bancel will provide strategic ... In addition to working closely with companies in ... President and Chief Executive Officer of Moderna Therapeutics, ...
(Date:5/22/2013)... NEW YORK , May 22, 2013  Ohr ... the development of novel therapeutics for unmet medical needs, ... Almenoff , M.D., Ph.D., to its Board of ... industry, working on early and late stage drug development. ... Almenoff join Ohr,s Board," said Dr. Irach Taraporewala, CEO ...
Breaking Medicine Technology:Life Line Screening and MCM Solutions for Better Health Announce New Partnership 2Life Science Industry Veteran Stephane Bancel Joins Flagship Ventures 2Life Science Industry Veteran Stephane Bancel Joins Flagship Ventures 3Ohr Pharmaceutical Appoints June S. Almenoff to Board of Directors 2Ohr Pharmaceutical Appoints June S. Almenoff to Board of Directors 3
... 2011 Argos Therapeutics, Inc. today announced that its late ... awarded the Nobel Prize in medicine for the discovery of ... Dr. Steinman,s discovery of dendritic cells and his research ... in adaptive immunity have led to the development of Argos, ...
... 4, 2011 Ingenious Med welcomes Chief Financial Officer, ... Adams will be responsible for the company,s financial, accounting, ... is an experienced executive with high growth companies such ... Med.  "His extensive financial background and experience will bring ...
Cached Medicine Technology:Argos Therapeutics' Late Scientific Co-founder Ralph Steinman, M.D., Awarded Nobel Prize in Medicine for Discovery of Dendritic Cells as Critical Sentinels of Immune System 2New Chief Financial Officer, Mark Adams, Joins Ingenious Med 2
(Date:5/22/2013)... Thompson HealthDay Reporter , , WEDNESDAY, May 22 ... back pain are more likely to attempt suicide, whether ... psychiatric condition, according to a new study. "Clinicians ... be aware they are at increased risk of suicide," ... Serious Mental Illness Treatment Resource and Evaluation Center in ...
(Date:5/22/2013)... Cedar Rapids, IA (PRWEB) May 22, 2013 ... inspirational theatre piece Handicap This! The performance promotes ... pursuing their dreams. The Handicap This! performance will be ... Linn Mar High School auditorium. Tickets for Handicap ... , Handicap This! helps audiences measure the level to ...
(Date:5/22/2013)... in genomic health disparities from the University of Miami ... of Medicine have teamed up to hold the second ... Disparities in Genomic Medicine." The theme of this ... and government to reduce these disparities. , Despite steady ... individuals within underserved groups continue to be more vulnerable ...
(Date:5/22/2013)... Hollow, New York (PRWEB) May 22, 2013 ... York, has established the Westchester Lung Nodule Center ... nodules or receive lung cancer care. Lung cancer is the ... Each year, more people in the U.S. die from lung ... , As with all cancers, early detection increases survival rates. ...
(Date:5/22/2013)... (PRWEB) May 22, 2013 Finding trustworthy, loving ... parents can do for their children. To help parents in ... chock-full of information about their nurturing programs, staff and ... captures the warm spirit of Paty’s Daycare,” said Patricia “Auntie ... feel welcome when you visit the new website, from the ...
Breaking Medicine News(10 mins):Health News:Migraine, Chronic Back Pain Tied to Higher Suicide Risk 2Health News:Migraine, Chronic Back Pain Tied to Higher Suicide Risk 3Health News:Handicap This! Comes to Marion, Iowa 2Health News:Why We Can't Wait: Conference to Eliminate Health Disparities in Genomic Medicine 2Health News:Phelps Memorial Hospital Center Establishes The Westchester Lung Nodule Center To Diagnose And Administer Lung Cancer Care 2Health News:Phelps Memorial Hospital Center Establishes The Westchester Lung Nodule Center To Diagnose And Administer Lung Cancer Care 3Health News:Paty’s Daycare Launches New Website to Connect with Parents in Need of Nurturing Child Care 2
... , Including Tips to Help Prevent the Spread of ... right around the corner, and H1N1 flu widespread across the ... and children celebrate safely this year. , (Logo: http://www.newscom.com/cgi-bin/prnh/20090108/RedCrossLOGO ... trick-or-treating and come home sick," said Sharon Stanley, Chief Nurse ...
... of a consultation room can improve the quality of ... study developed by Nurture by Steelcase and Mayo Clinic, ... consultation room designed to support present-day clinical encounters could ... of this randomized trial, the first of its kind, ...
... Even though no-one wants to admit it,the countdown to Christmas is upon ... then follow the realbuzz.com guide to a healthier,you. You know that once ... so now,s the time to turn your body into a temple. , ... didn,t offer this piece of,advice to start with! If you don,t already ...
... ... Companies, Families and Communities in Tri-State Area , ... Pittsburgh, P.A. (PRWEB) October 28, 2009 ... compensation facility in Western Pennsylvania, this week unveiled the new AlleghenyMedical.com--a one-stop destination ...
... ... Diabetes Patients to Reduce Hospital Readmission , ... Atlanta, Georgia (PRWEB) October 28, 2009 -- The IN Compass ... Quality Award for the team,s project "Indigent Diabetic Patient Follow-Up Care Program" at the ...
... ... medicine and recently demonstrated its technology by creating three free e-books on H1N1 ... to empower e-patients and technologically enable participatory medicine. , ... Los Altos, CA (PRWEB) October ...
Cached Medicine News:Health News:Red Cross Offers the 'Trick' to Safety this Halloween 2Health News:Researchers find room design can enhance patient care 2Health News:The Countdown to Christmas - The realbuzz.com Guide to a Healthier You! 2Health News:Allegheny Medical Announces Launch of the New AlleghenyMedical.com 2Health News:Allegheny Medical Announces Launch of the New AlleghenyMedical.com 3Health News:IN Compass Health's Hospitalist Team at Morton Plant Wins First BayCare Quality Award 2Health News:IN Compass Health's Hospitalist Team at Morton Plant Wins First BayCare Quality Award 3Health News:IN Compass Health's Hospitalist Team at Morton Plant Wins First BayCare Quality Award 4Health News:Resounding Health Receives Small Business Innovation Research Award from the National Institutes of Health 2Health News:Resounding Health Receives Small Business Innovation Research Award from the National Institutes of Health 3
... Bulb Direct has been selling ... since 1996, and we are ... satisfaction guarantee. Check out our ... see our discount light bulbs ...
... Bulb Direct has been selling ... since 1996, and we are ... satisfaction guarantee. Check out our ... see our discount light bulbs ...
... has been selling replacement bulbs ... and we are extremely proud ... Check out our catalog of ... discount light bulbs specials. ...
... has been selling replacement bulbs ... and we are extremely proud ... Check out our catalog of ... discount light bulbs specials. ...
Medicine Products: